Myasthenia gravis; cytotoxic potential of human sera in vitro and novel non-antibody, disease-modifying factors

Helgeland, Geir

Helgeland, Geir

Doctoral thesis

View/Open

Main thesis (626.8Kb)

URI

https://hdl.handle.net/1956/4422

Date

2010-10-22

Metadata

Show full item record

Collections

Department of Clinical Medicine [1000]

Has parts

Paper I: Muscle & Nerve 33(1), Luckman, S, P.; Skeie, G. O.; Helgeland, G.; Gilhus, N. E., Morphological effects of myasthenia gravis patient sera on human muscle cells, pp. 93-103. Copyright 2005 Wiley Periodicals. Full text not available in BORA due to publisher restrictions. The published version is available at: http://dx.doi.org/10.1002/mus.20443

Paper II: Journal of Neuroimmunology 201-202, Helgeland, G.; Luckman, S. P.; Romi, F. R.; Jonassen, A. K.; Gilhus, N. E., Myasthenia gravis sera have no effect on cardiomyocytes in vitro, pp. 74-79. Copyright 2008 Elsevier. Full text not available in BORA due to publisher restrictions. The published version is available at: http://dx.doi.org/10.1016/j.jneuroim.2008.05.021

Paper III: Journal of Neuroimmunology 225(1-2), Helgeland, G.; Petzold, A.; Hoff, J. M.; Gilhus, N. E.; Plant, G. T.; Romi, F. R., Anti-Heat Shock Protein 70 antibody levels are increased in myasthenia gravis and Guillain-Barre syndrome, pp. 180-183. Copyright 2010 Elsevier. Full text not available in BORA due to publisher restrictions. The published version is available at: http://dx.doi.org/10.1016/j.jneuroim.2010.04.024

Paper IV: European Neurology 65(1), Helgeland, G.; Petzold, A.; Luckman, S. P.; Gilhus, N. E.; Plant, G. T.; Romi, F. R., Matrix metalloproteinases in Myasthenia Gravis, pp. 53-58. Copyright 2011 S. Karger. Full text not available in BORA due to publisher restrictions.

Publisher

The University of Bergen